|1.||Nemeth, Edward F: 1 article (11/2008)|
11/01/2008 - "The daily subcutaneous administration of ZT-031 to postmenopausal women with osteoporosis elicited a dose-dependent increase in BMD of the lumbar spine, proximal femur and total hip area. "
11/01/2008 - "ZT-031, a cyclized analog of parathyroid hormone(1-31) for the potential treatment of osteoporosis."
11/01/2008 - "Daily subcutaneous injections of ZT-031 prevented bone loss and replaced bone that had already been lost in an ovariectomized rat model of osteoporosis. "
11/01/2008 - "ZT-031 is a cyclic 31-amino acid analog of parathyroid hormone (PTH) that is in development by Zelos Therapeutics Inc for the treatment of osteoporosis and other bone-related disorders. "
|2.||Hypercalcemia (Milk Alkali Syndrome)
|1.||Parathyroid Hormone (Parathormone)